Posted by Michael Wonder on 18 Sep 2023
The problem of limited supply agreements for Medicare price negotiation
15 September 2023 - Pharmaceutical manufacturers charge high prices for their products during periods of market exclusivity that end when generic manufacturers reach the market with competing products.
In the US, generic competition is the only market force that consistently and substantially lowers spending on prescription drugs, so naturally, brand-name manufacturers use a range of strategies to combat generic competition.
